Related Experiment Video

Updated: Jul 4, 2026

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression
06:03

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression

Published on: January 19, 2019

Unmet need in lung cancer: can vaccines bridge the gap?

Jae Kim1, Dan Raz, David Jablons

  • 1Department of Surgery, University of California San Francisco Cancer Center, San Francisco, CA 94143-1724, USA.

Clinical Lung Cancer
|June 11, 2008
PubMed

Insights

Lung cancer survival remains poor, but cancer vaccines offer a promising, low-toxicity therapy. Novel vaccine delivery strategies are being explored in clinical trials to improve treatment outcomes.

Area of Science:

  • Oncology
  • Immunology
  • Vaccinology

Background:

  • Lung cancer treatments have limited efficacy, with poor median survival rates.
  • There is a critical need for novel, effective, and low-toxicity therapies.
  • Cancer vaccines present a potential solution to address this unmet need.

Purpose of the Study:

  • To review the rationale for using cancer vaccines in lung cancer treatment.
  • To discuss various strategies for delivering cancer vaccines.
  • To summarize current clinical trials involving lung cancer vaccines.

Main Methods:

  • Review of existing literature on lung cancer immunology and vaccine strategies.
  • Analysis of novel vaccine delivery methods, including adjuvants, genetic modification, viral vectors, and antigen-presenting cells.
  • Examination of data from clinical trials of cancer vaccines in lung cancer patients.

Main Results:

  • Cancer vaccines are being developed using advanced immunological approaches.
  • Multiple vaccine delivery strategies show promise for enhancing anti-tumor immunity.
  • Several vaccine strategies have been evaluated in clinical trials for lung cancer.

Conclusions:

  • Cancer vaccines represent a viable therapeutic avenue for lung cancer.
  • Further research and clinical trials are essential to optimize vaccine efficacy.
  • Vaccine therapy holds potential for improving survival and reducing toxicity in lung cancer patients.

More Related Videos

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.